1 2 3 4 5 Next
Antibiotic inhibits cancer gene activity
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors, according to researchers at the University of Illinois at Chicago College of Medicine. (Sun, 01 Oct 2006 04:08:32 GMT)
Antibiotic Inhibits Cancer Gene Activity
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors. (Sun, 01 Oct 2006 05:24:35 GMT)
IU, Purdue Scientists Selected For Major National Cancer Institute Initiative
The National Institutes of Health's National Cancer Institute (USA) has selected a team of scientists from Indiana and Purdue universities to assess and develop the next generation of tools to improve biomarker discovery. Such biomarkers should lead to better prevention, diagnosis and treatment of cancer. [click link for full article] (Sun, 01 Oct 2006 07:11:18 GMT)
AACR CEO Margaret Foti Receives Cancer Service Award
American Association for Cancer Research Chief Executive Officer Margaret Foti, Ph.D., M.D. (h.c.) will receive the Association of American Cancer Institutes (AACI) Distinguished Service Award for her outstanding contributions to progress in cancer research. The award will be presented during a special ceremony at the AACI's annual meeting, October 22 - 24, 2006. [click link for full article] (Sun, 01 Oct 2006 07:11:28 GMT)
Around Indiana
Mayor James Garner has appointed Tim Deatrick, a part-time researcher and student at Indiana University Southeast, as the final member of the city's new Stormwater Board. (Sun, 01 Oct 2006 09:50:04 GMT)
3-D Brain Atlas To Help Unlock Mysteries Of Neurological Disorders
The Allen Institute for Brain Science has announced the completion of the groundbreaking Allen Brain Atlas, a Web-based, three-dimensional map of gene expression in the mouse brain. Detailing more than 21,000 genes at the cellular level, the Atlas provides scientists with a level of data previously not available. (Sun, 01 Oct 2006 12:49:53 GMT)
How Fast Does Dark Matter Fall?
Dark matter is mysterious stuff. Scientists don't really know much about it at all, other than the fact that there seems to be a lot of it in the universe. Thanks to a new analysis by physicists at Caltech and the University of Toronto, we can expect that lumps of dark matter gravitationally attract each other in just the same way that lumps of normal matter (like you and the earth, for instance) (Sun, 01 Oct 2006 12:50:12 GMT)
Stock Offerings This Week
The following equity and convertible debt offerings are expected this week:. (Mon, 02 Oct 2006 04:59:51 GMT)
Relationship Targets Significant Expansion of QIAGEN's Portfolio of Molecular Tests for Infectious Diseases in the
QIAGEN N.V. , a leading provider of molecular diagnostics products and the world's premier supplier of solutions for preanalytical sample preparation, today announced that it has entered a strategic agreement with the British Veterinary Laboratories Agency , one of the world's leading laboratories in the field of veterinary testing. (Mon, 02 Oct 2006 06:00:00 GMT)
Berkeley Lab Life Scientists Are Leaders In Team To Detect Cancer By Studying Proteins In The Blood
The National Cancer Institute (NCI) today announced awards totaling over $35.5 million to establish a network of teams that will investigate how to detect cancer by finding cancer-specific proteins and protein patterns in blood samples. [click link for full article] (Mon, 02 Oct 2006 07:10:07 GMT)
GNI Group Sees Demand for Synthetic Bone Material Product in China
TOKYO----GNI Ltd, a leading biopharmaceutical company in Asia, has announced that its China based affiliate Shanghai Genomics has expanded sales of Gu-Bang, a new type of synthetic bone biomaterial, after winning several hospital supply contracts in Beijing, Shanghai and Guandong province. (Mon, 02 Oct 2006 07:19:00 GMT)
Bio-IT Briefs
October 02, 2006 | Millennium Pharmaceuticals Inc . has entered into an agreement to acquire AnorMED Inc ., a Canada-based biopharmaceutical company with a late-stage Phase III hematology-oncology product, Mozobil. (Mon, 02 Oct 2006 08:14:56 GMT)
GNI Group Sees Demand for Synthetic Bone Material Product in China
GNI Ltd, a leading biopharmaceutical company in Asia, has announced that its China based affiliate Shanghai Genomics has expanded sales of Gu-BangTM, a new type of synthetic bone biomaterial, after winning several hospital supply contracts in Beijing, Shanghai and Guandong province. (Mon, 02 Oct 2006 08:20:23 GMT)
Acacia Technologies Licenses Resource Scheduling Technology to 3M Company
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that Resource Scheduling Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has entered into a license with 3M Company covering a patent that applies to systems for scheduling and managing resources. (Mon, 02 Oct 2006 10:02:00 GMT)
TECHWORKING
LCG Systems plans to hire about five people in the next month and a half. Howard Stern, vice president of business development, talked with The Post's Judith Mbuya. (Mon, 02 Oct 2006 11:10:32 GMT)
Acacia Technologies Licenses Resource Scheduling Technology to 3M Company
NEWPORT BEACH, Calif., (Mon, 02 Oct 2006 11:30:25 GMT)
Acacia Technologies Licenses Multi-Dimensional Bar Code Technology to Allstate Insurance Company
NEWPORT BEACH, Calif., (Mon, 02 Oct 2006 11:30:35 GMT)
Acacia Technologies Licenses Multi-Dimensional Bar Code Technology to Texas Instruments
NEWPORT BEACH, Calif., (Mon, 02 Oct 2006 11:30:45 GMT)
QIAGEN and VLA Enter Into Agreement in Veterinary Testing
QIAGEN N.V. (NASDAQ: QGEN)(Frankfurt, Prime Standard: QIA), a leading provider of moleculardiagnostics products and the world's premier supplier of solutions forpreanalytical sample preparation, today announced that it has entered astrategic agreement with the British Veterinary Laboratories Agency (VLA),one of the world's leading laboratories in the field of veterinary testing. (Mon, 02 Oct 2006 11:31:08 GMT)
InnovationWell Discusses Innovation in Life Science & Healthcare Research & Product Development
Zeiningen, Switzerland (PRWEB) October 2, 2006 -- The InnovationWell Community of Practice InterAction Meeting "Innovation in Life Science & Healthcare Research & Product Development" will take place 16-19 October 2006, Bryn Mawr College, Philadelphia, USA. (Mon, 02 Oct 2006 12:00:00 GMT)
QIAGEN and VLA Enter Into Agreement in Veterinary Testing
QIAGEN N.V. (NASDAQ: QGEN)(Frankfurt, Prime Standard: QIA), a leading provider of moleculardiagnostics products and the world's premier supplier of solutions forpreanalytical sample preparation, today announced that it has entered astrategic agreement with the British Veterinary Laboratories Agency (VLA),one of the world's leading laboratories in the field of veterinary testing. (Mon, 02 Oct 2006 12:45:34 GMT)
Genetic 'Roadmap' Charts Links Between Drugs And Human Disease
A research team led by scientists at the Broad Institute of MIT and Harvard developed a new kind of genetic "roadmap" that can connect human diseases with potential drugs to treat them, as well as predict how new drugs work in human cells. Called the "Connectivity Map," the tool and its uses are described in the September 29 issue of Science and in separate publications in the September 28 (Mon, 02 Oct 2006 12:49:31 GMT)
Cloned Mice Created From Fully Differentiated Cells, A Milestone In Cloning Research
New research dismisses the notion that adult stem cells are necessary for successful animal cloning, proving instead that cells that have completely evolved to a specific type not only can be used for cloning purposes, but they may be better and more efficient. As proof, researchers report they created two mouse pups from a type of blood cell that itself is incapable of dividing to produce a (Mon, 02 Oct 2006 12:49:44 GMT)
Gene Key To Taste Bud Development Identified
Scientists have identified a gene that controls the development of taste buds. The gene, SOX2, stimulates stem cells on the surface of the embryonic tongue and in the back of the mouth to transform into taste buds, according to the researchers. Stem cells are immature cells that can develop into several different cell types depending on what biochemical instructions they receive. (Mon, 02 Oct 2006 12:50:58 GMT)
Antibiotic Inhibits Cancer Gene Activity
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors, according to researchers at the University of Illinois at Chicago College of Medicine. (Mon, 02 Oct 2006 12:52:05 GMT)
Clintons have a blast watching Bills at stadium
Yes, that was Sen. Hillary Rodham Clinton and her husband, the former president, cheering during the Buffalo Bills' victory Sunday afternoon at Ralph Wilson Stadium. (Mon, 02 Oct 2006 12:53:50 GMT)
Major Cancer Study Aims To Identify Protein Markers For Early-stage Disease
A team led by Bay Area scientists is one of five nationwide to receive a major grant from the National Cancer Institute (NCI) to refine and standardize the technologies for identifying biomarkers in the blood -- specific proteins, and the patterns they make -- for the early detection of cancer. [click link for full article] (Mon, 02 Oct 2006 13:11:20 GMT)
Tsakos Names Aristides Patrinos to Board
Greek oil shipper Tsakos Energy Navigation Ltd. on Monday said its has named Aristides A. N. Patrinos to the board. Patrinos is president of Synthetic Genomics, a company developing synthetic biology advances in the energy field. (Mon, 02 Oct 2006 13:24:33 GMT)
Tsakos names Aristides Patrinos to board
Patrinos is president of Synthetic Genomics, a company developing synthetic biology advances in the energy field. He previously worked for the Energy Department\'s Office of Science, where he was director of the Office of Biological and Environmental Research. (Mon, 02 Oct 2006 13:29:15 GMT)
Molecular atlas provides new tool for understanding estrogen-fueled breast cancer
BOSTON -- Lurking in unexplored regions of the human genome are thousands of previously unknown on/off switches that may influence how the growth of breast cancer is driven by estrogen, new research by Dana-Farber Cancer Institute researchers has revealed. (Mon, 02 Oct 2006 14:58:51 GMT)
Ex-QB Kelly on receiving end of federal aid
Before Sen. Hillary Rodham Clinton attended Sunday's Buffalo Bills home game, she scored a touchdown with the team's Hall of Fame quarterback, Jim Kelly. (Mon, 02 Oct 2006 17:33:09 GMT)
Special Delivery from Remote-Controlled Nanocarriers
Work has been done on developing drug-filled nanocarriers via a magnetic field, but a more concentrated approach to targeting tumors, which could reduce side effects, may be needed. Research at the State University of New York (SUNY) in Buffalo shows promise. (Mon, 02 Oct 2006 17:33:51 GMT)
Mistral Pharma to Present at BioContact 2006
Mistral Pharma Inc. announced today that it will be a presenter at the BIOCONTACT 2006 conference at the Chateau Frontenac in Quebec city. This presentation will be given by Mr. Bertrand Bolduc, President and Chief Executive Officer of Mistral Pharma, on October 6, 2006 in the Bellevue room at 10 a.m. (Mon, 02 Oct 2006 17:43:00 GMT)
Mistral Pharma to Present at BioContact 2006
MONTREAL, QUEBEC-- - Mistral Pharma Inc. announced today that it will be a presenter at the BIOCONTACT 2006 conference at the Chateau Frontenac in Quebec city. This presentation will be given by Mr. (Mon, 02 Oct 2006 17:43:18 GMT)
Springer's Journal Of Robotic Surgery Positioned To Become Leading Resource For Robotic Techniques In Surgery
Springer, one of the world's leading science, technology, and medicine publishers, is launching the Journal of Robotic Surgery. This new journal will be the first to focus exclusively on emerging robotic applications in surgery, and is positioned to become the world's foremost clinical resource for robotic surgical education. Four issues will be published annually, starting January 2007. [click (Mon, 02 Oct 2006 18:10:19 GMT)
Dr. Tim Tingkang Xia to be Guest Speaker At World Renowned China Hi-Tech Fair
Tim Tingkang Xia, Ph. D., a partner in the Intellectual Property Practice and International Practice at Morris Manning & Martin LLP, has been invited to speak at the 2006 China Hi-Tech Fair, held at the Shenzhen Convention and Exhibition Center in China on October 14, 2006. (Mon, 02 Oct 2006 18:52:22 GMT)
Molecular Atlas Provides New Tool for Understanding Estrogen-fueled Breast Cancer
Dana-Farber investigators have developed the first complete map of the molecular "control panels" operated by the cells' estrogen receptor, the master regulator of cell growth in the most common form of breast cancer. This may eventually help doctors match patients with treatments that are most likely to be effective and overcome the problem of resistance to current hormone therapies. (Mon, 02 Oct 2006 19:24:35 GMT)
Yale Tomorrow Campaign Establishes $3 Billion Goal
New Haven, Conn. — The University has launched a five-year, $3 billion “ Yale Tomorrow ” campaign to expand its capacity to contribute to a global society through its scholarship and graduates. (Mon, 02 Oct 2006 20:50:22 GMT)
'Gene Silencing' Discoverers Win Nobel Prize
The Prize in Physiology or Medicine for 2006 has been awarded jointly to Andrew Z. Fire and Craig C. Mello for their discovery of "RNA interference -- gene silencing by double-stranded RNA" -- a fundamental mechanism for controlling the flow of genetic information. (Mon, 02 Oct 2006 21:48:48 GMT)
Mistral Pharma to Present at BioContact 2006
Mistral Pharma Inc. (TSX VENTURE: MIP) announced today that it will be a presenter at the BIOCONTACT 2006 conference at the Chateau Frontenac in Quebec city. This presentation will be given by Mr. Bertrand Bolduc, President and Chief Executive Officer of Mistral Pharma, on October 6, 2006 in the Bellevue room at 10 a.m. (Mon, 02 Oct 2006 22:14:37 GMT)
Sorenson branches out to forensics
Posted: 3:58 PM- Sorenson Genomics hopes to expand on its worldwide renown for DNA-testing expertise with launch of a biological forensics division. Sorenson Forensics plans to be a helping-hand-for-hire to federal, state and metropolitan crime laboratories as well as trial attorneys. The division will also take on missing persons and private industry work, said Doug Fogg, chief (Mon, 02 Oct 2006 22:16:07 GMT)
ATI Will Tune Its Graphics Chips For High-Performance Apps
The plan by ATI, which is set to merge with chip maker Advanced Micro Devices this month, could give AMD a competitive edge against Intel in the fast-growing market for high-performance computing. (Mon, 02 Oct 2006 22:41:49 GMT)
Surveys shape museum exhibits on science
When the results of its latest survey came back, officials at the American Museum of Natural History were hardly astonished. (Mon, 02 Oct 2006 23:10:25 GMT)
Massively Parallel Trims, Refuses
By Matt Branaugh, Daily Camera, Boulder, Colo. Sep. (Tue, 03 Oct 2006 01:11:02 GMT)
IU, Purdue Selected For Major NCI Biomarker Tools Initiative
The National Institutes of Health's National Cancer Institute has selected a team of scientists from Indiana and Purdue universities to assess and develop the next generation of tools to improve biomarker discovery. Such biomarkers should lead to better prevention, diagnosis and treatment of cancer. [click link for full article] (Tue, 03 Oct 2006 02:09:59 GMT)
Children's, UPMC get $12.8 million grant for lung disease research
Pulmonary researchers at Children's Hospital and the University of Pittsburgh School of Medicine have received a $12.8 million federal grant to study how individual differences influence the development of certain lung conditions. (Tue, 03 Oct 2006 04:08:16 GMT)
New branch reaches into full-blown forensics
Sorenson Genomics hopes to expand on its worldwide renown for DNA-testing expertise with today's launch of a biological forensics division. Sorenson Forensics plans to be a helping-hand-for-hire to federal, state and metropolitan crime laboratories, as well as trial attorneys. The division also will take on missing persons and private industry work, said Doug Fogg, chief operating officer for (Tue, 03 Oct 2006 06:03:23 GMT)
No clue is too small for lab
The evidence seems innocent enough a shirt, a sock, a pair of shoes. But a closer look reveals a darker secret saliva, semen, a blood stain. At Sorenson Forensics, a team of nine people is now dedicating its efforts to solving society's worst crimes. (Tue, 03 Oct 2006 06:26:05 GMT)
How to become a bio-informaticist
This is a job for people who are fascinated by biology and technology, and are not afraid of mathematics. (Tue, 03 Oct 2006 11:06:08 GMT)
Sorenson Genomics Launches New Advanced Sorenson Forensics Division
SALT LAKE CITY & SAN FRANCISCO----Sorenson Genomics, a leading global provider of DNA-related testing services, announced today at the 2006 American Society of Crime Laboratory Directors Symposium that it has expanded its core business offering with the addition of an advanced forensics division. (Tue, 03 Oct 2006 11:30:00 GMT)
RNA Interference Technology's "Home Run" Potential
Rob Zenilman submits: Excerpt from our One-Page WSJ Summary: Nobel Discovery Already Sparked Hunt for Drugs Summary: This years winners of Nobel prize for medicine was awarded to Andrew Fire and Craig Mello for research they did back in 1988. (Tue, 03 Oct 2006 11:35:52 GMT)
GeneGo, Inc. Is Awarded Phase II NCI Grant for Network Biomarkers in Breast Cancer
GeneGo, Inc., a leading provider of software and databases for systems biology and pathway analysis, announced today that they have been awarded a Phase II SBIR grant from the National Cancer Institute for discovery of new biomarkers implicated in breast cancer based on network analysis. (Tue, 03 Oct 2006 12:00:00 GMT)
QuantRx(R) Biomedical's FluoroPharma Unit to Begin Phase I Clinical Trials for CardioPET(TM) Imaging Agent for Coronary
QuantRx® Biomedical Corporation, an emerging leader in the research and development of medical diagnostic platforms and products, is pleased to announce that its affiliate company FluoroPharma, Inc. has begun Phase I clinical trials for CardioPET(TM), a novel cardiac viability imaging agent. (Tue, 03 Oct 2006 12:23:00 GMT)
Gene: Antibiotic Inhibits Cancer Gene Activity
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors, according to researchers at the University of Illinois at Chicago College of Medicine (Tue, 03 Oct 2006 14:05:53 GMT)
Genome archaeology illuminates the genetic engineering debate
NEW BRUNSWICK/PISCATAWAY, N.J. -- Genome Research's cover story for Oct. 2 tells a tale of "genome archaeology" by genetic researchers who dug deeply into the long history of maize and rice. (Tue, 03 Oct 2006 14:50:31 GMT)
X PRIZE Foundation to Announce Second Major Prize for Breakthrough in Genomics
WASHINGTON----The non-profit X PRIZE Foundation has created a unique philanthropic prize model designed to stimulate research and accelerate development of radical breakthroughs that will benefit humanity. (Tue, 03 Oct 2006 15:26:00 GMT)
Molecular Atlas Provides New Tool For Understanding Estrogen-fueled Breast Cancer
Lurking in unexplored regions of the human genome are thousands of previously unknown on/off switches that may influence how the growth of breast cancer is driven by estrogen, new research by Dana-Farber Cancer Institute researchers has revealed. (Tue, 03 Oct 2006 15:49:18 GMT)
Surveys shape museum exhibits on science
As issues such as global climate and evolution increasingly become part of public discussion, institutions like the Natural History museum are finding their roles as educators expanding. (Tue, 03 Oct 2006 15:51:00 GMT)
Salmonella Exposed Through Proteomics: An Infectious Agent Of Deception
Salmonella bacteria, infamous for food poisoning that kills hundreds of thousands worldwide, infect by stealth. They slip unnoticed into and multiply inside macrophages, the very immune system cells the body relies on to seek and destroy invading microbes. [click link for full article] (Tue, 03 Oct 2006 16:10:08 GMT)
QuantRx(R) Biomedical's FluoroPharma Unit to Begin Phase I Clinical Trials for CardioPET(TM) Imaging Agent for Coronary
QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medicaldiagnostic platforms and products, is pleased to announce that itsaffiliate company FluoroPharma, Inc. has begun Phase I clinical trials forCardioPET(TM), a novel cardiac viability imaging agent. The product hasbeen developed to allow acute and chronic coronary artery disease to beassessed (Tue, 03 Oct 2006 16:26:51 GMT)
Genome archaeology illuminates the genetic engineering debate
Genome Research ’s cover story for Oct. 2 tells a tale of “genome archaeology” by genetic researchers who dug deeply into the long history of maize and rice. Their resulting insights into plant genomic evolution may well fuel the fires of the genetically modified organism (GMO) controversy. (Tue, 03 Oct 2006 16:59:28 GMT)
Rosetta Genomics pricing expected tomorrow
The company plans to raise $33-39 million at a company value of $116-137 million. (Tue, 03 Oct 2006 17:26:05 GMT)
Studies in Translational Research: Bench to Bedside
The pulse of translational research is quickening throughout UCSF. Among the numerous endeavors under way are several that represent different disease areas and tactics. (Tue, 03 Oct 2006 17:26:57 GMT)
$83.5 million NIH grant to Pitt establishes Clinical and Translational Research Institute
PITTSBURGH, Oct. 3 – The University of Pittsburgh is among the first institutions selected by the National Institutes of Health (NIH) to receive a Clinical and Translational Science Award, joining 11 other academic health centers in a new consortium that aims to transform how clinical and translational research is conducted so that promising treatments can be more readily available to patients. (Tue, 03 Oct 2006 17:58:23 GMT)
Rockefeller University receives $45 million from NIH for clinical and translational science
The National Center for Research Resources at the National Institutes of Health announced today that Rockefeller University has been awarded one of the first Clinical and Translational Science Awards (CTSA), a component of the NIH Roadmap designed to transform clinical and translational research so that new treatments can be developed more efficiently and delivered more quickly to patients. (Tue, 03 Oct 2006 17:58:34 GMT)
Cancer Gene Activity Inhibited By Antibiotic
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors, according to researchers at the University of Illinois at Chicago College of Medicine.Their findings appear in the Oct. 1 issue of Cancer Research. [click link for full article] (Tue, 03 Oct 2006 18:10:44 GMT)
Chicago chip maker raising stake in Arizona
A Chicago chip manufacturer is mulling a full-scale move to Arizona as commerce groups and industry advocates try to sway the company from the Windy City. (Tue, 03 Oct 2006 20:21:05 GMT)
Yale School of Medicine awarded $57 million for bench-to-bedside research
New Haven, Conn.--As part of a major national initiative to speed research from the laboratory bench to patients in need, Yale School of Medicine Tuesday received a $57.3 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH). (Tue, 03 Oct 2006 20:43:26 GMT)
Yale School of Medicine Awarded $57 Million for Bench-to-Bedside Research
New Haven, Conn. — As part of a major national initiative to speed research from the laboratory bench to patients in need, Yale School of Medicine Tuesday received a $57.3 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH). (Tue, 03 Oct 2006 21:20:22 GMT)
RNA Interference-Based Gene Silencing As an Efficient Tool for Functional Genomics in Hexaploid Bread Wheat1[W][OA]
By Travella, Silvia; Klimm, Theres E; Keller, Beat Insertional mutagenesis and gene silencing are efficient tools for the determination of gene function. (Tue, 03 Oct 2006 22:15:33 GMT)
$45 Million NIH Grant to Rockefeller for Clinical, Translational Science
With its Clinical and Translational Science Award, Rockefeller University has established the Center for Clinical and Translational Science and a new training program for physician-scientists entering careers in translational research. (Tue, 03 Oct 2006 22:24:56 GMT)
NIH: $45M to Speed Science to Doc's Office
The National Institutes of Health have given $45 million for research to shorten the time it takes medical breakthroughs to reach patients. (Wed, 04 Oct 2006 00:11:21 GMT)
Looking ahead
The Wednesday whirl: • The Nobel Prize in chemistry will be announced. • Eyes on the the other prize: The X PRIZE Foundation, which sponsors the largest medical prize in history, announces a second award for breakthroughs in genomics. • Economic numbers:... (Wed, 04 Oct 2006 01:01:53 GMT)
University of Oklahoma Deploys Ariadne Pathway Studio to Create Cancer-related Pathway Collection
Ariadne Genomics, Inc. today announced that the University of Oklahoma Health Sciences Center (Oklahoma City, OK) has deployed its Pathway Studio software solution to develop a comprehensive collection of cancer-related pathways. The collection will be made available to Ariadne customers at no charge as an add-on to the pathway analysis product line. (PRWEB Oct 4, 2006) (Wed, 04 Oct 2006 07:16:37 GMT)
UCSC Genome Browser Tutorial at ASHG 2006
OpenHelix presents “Introduction to the UCSC Genome Browser” tutorial at the American Society of Human Genetics 2006 annual meeting in New Orleans. (PRWEB Oct 4, 2006) Trackback URI: http://www.prweb.com/zingpr.php/U2luZy1Db3VwLUZhbHUtU3VtbS1JbnNlLVplcm8= (Wed, 04 Oct 2006 07:34:59 GMT)
Lawrence Berkeley National Laboratory and OpenHelix Announce Comprehensive Training Programs for VISTA: Tools for
(PRWEB Oct 4, 2006) Trackback URI: http://www.prweb.com/zingpr.php/TWFnbi1TaW5nLUZhbHUtU3VtbS1JbnNlLVplcm8= (Wed, 04 Oct 2006 07:35:11 GMT)
American Association of Pharmaceutical Scientists (AAPS)
Halloween is the time to visit San Antonio , Texas , but not just for the festivities on their famous Riverwalk. Just a block away from the river, the gather from October 29-November 2, 2006 for the 2006 AAPS Annual Meeting and Exposition. (Wed, 04 Oct 2006 08:59:47 GMT)
USF team presents at program
Five University of St. Francis faculty members will present at the annual Associated Colleges of the Chicago Area Symposium on "The Scholarship of Pedagogy." The university will also host the symposium from 8 a.m. to 2:30 p.m. Saturday. (Wed, 04 Oct 2006 09:37:01 GMT)
Duke University's Center for Human Genetics Selects Illumina's Infinium HumanHap550 BeadChip for Landmark Autism Study
SAN DIEGO----Illumina, Inc. announced today that Duke University's Center for Human Genetics has selected the Infinium HumanHap550 BeadChip for an Autism study of over 1,800 individuals and their families. (Wed, 04 Oct 2006 10:00:00 GMT)
Genome on-off switches mapped
To understand a sequenced genome, scientists need to know where and when the genes are switched on - that has come closer for the "lab rat" of the plant world (Wed, 04 Oct 2006 10:05:10 GMT)
UCSC Genome Browser Tutorial at ASHG 2006
(PRWEB) October 4, 2006 -- The UCSC Bioinformatics Group announces the sponsorship of a one hour seminar at the American Society of Human Genetics (ASHG) 2006 meeting on October 11th, 1: (Wed, 04 Oct 2006 12:00:00 GMT)
Lawrence Berkeley National Laboratory and OpenHelix Announce Comprehensive Training Programs for VISTA: Tools for
Seattle, WA (PRWEB) October 4, 2006 -- The Lawrence Berkeley National Laboratory (LBNL) has contracted with OpenHelix to provide revolutionary and comprehensive training and outreach programs for its free web based genomics resource, VISTA. (Wed, 04 Oct 2006 12:00:00 GMT)
PsychoGenics Appoints Rusiko Bourtchouladze, Ph.D., as Vice President, Cognition and Discovery Research
PsychoGenics Inc. announced the appointment of Rusiko Bourtchouladze, Ph.D., as Vice President, Cognition and Discovery Research. (Wed, 04 Oct 2006 12:00:00 GMT)
NHGRI Aims to Make DNA Sequencing Faster, More Cost Effective
Bethesda, Md. – The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced the latest round of grant awards totaling more than $13.3 million to speed the development of innovative sequencing technologies that reduce the cost of DNA sequencing and expand the use of genomics in medical research and health care. (Wed, 04 Oct 2006 12:37:32 GMT)
Lumera Signs New Agreement with Institute for Systems Biology to Address Cancer Detection
BOTHELL, Wash.----Lumera Corporation , the world's leading provider of light applied nanotechnology, announced an expanded collaboration agreement with the Institute for Systems Biology , an internationally renowned non-profit research institute dedicated to the study and application of systems biology. (Wed, 04 Oct 2006 12:45:00 GMT)
RedChip Audio/Video Interview With Genesis Bioventures, Inc. Airing Now on RedChip.com
Dave Gentry, President of RedChip Companies, Inc., recently conducted an audio/video interview with Douglas C. Lane, President, CEO, and Chairman of Genesis Bioventures, Inc. . The audio/video interview is currently airing on RedChip.com. (Wed, 04 Oct 2006 12:49:48 GMT)
Lumera Signs New Agreement with Institute for Systems Biology to Address Cancer Detection
Lumera Corporation ( Nachrichten ) (NASDAQ:LMRA), the world ' s leading provider of light applied nanotechnology, announced an expanded collaboration agreement with the Institute for Systems Biology (ISB), an internationally renowned non-profit research institute dedicated to the study and application of systems biology. (Wed, 04 Oct 2006 12:54:53 GMT)
NHGRI aims to make DNA sequencing faster, more cost effective
BETHESDA, Md., Wed., Oct. ,4, 2006 – The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced the latest round of grant awards totaling more than $13 million to speed the development of innovative sequencing technologies that reduce the cost of DNA sequencing and expand the use of genomics in medical research and health care. (Wed, 04 Oct 2006 13:05:28 GMT)
Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million
Drug Royalty Corporation Inc. and Nanogen Inc. announced today that they have entered into an agreement for a trust managed by DRC to acquire an interest in royalties on the MGB technology owned by Nanogen for 5' nuclease real-time PCR applications in the biomedical research market. (Wed, 04 Oct 2006 14:47:00 GMT)
Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million
TORONTO, and SAN DIEGO, Oct. 4 /PRNewswire/ -- Drug Royalty Corporation Inc. (DRC) and Nanogen Inc. ( Nachrichten ) announced today that they have entered into an agreement for a trust managed by DRC to acquire an interest in royalties on the MGB(TM) (minor groove binder) technology owned by Nanogen for 5' nuclease real-time PCR applications in the biomedical research market. (Wed, 04 Oct 2006 14:55:13 GMT)
Genome Archaeology Illuminates The Genetic Engineering Debate
Genome Research's cover story for October 2 tells a tale of "genome archaeology" by genetic researchers who dug deeply into the long history of maize and rice. Their resulting insights into plant genomic evolution may well fuel the fires of the genetically modified organism (GMO) controversy. (Wed, 04 Oct 2006 15:48:57 GMT)
Slippery Salmonella: Proteomics Exposes An Infectious Agent Of Deception
How Salmonella escapes detection by macrophages, turning predator cells to prey complicit in promoting infection, has seemed impossibly complicated, a needle-in-a-haystack proposition involving thousands of proteins, the building blocks that carry out cells' vital functions. Now, applying the high-volume sorting and analytical power of proteomics -- a detailed survey of microbial proteins present (Wed, 04 Oct 2006 15:49:37 GMT)
Clinical Data and Algynomics to Commercialize Proprietary Genetic Pain Panel
NEWTON, Mass.----Clinical Data, Inc. announced today that its Cogenics Division has signed an agreement to provide genomic testing services to the pain research community based on Algynomics' proprietary panel of genetic markers. (Wed, 04 Oct 2006 17:08:00 GMT)
$10 million prize aims to inspire gene race
The foundation that inspired a private sector race to space announced a new $10 million prize on Wednesday -- this time to inspire a race to sequence the human genetic map faster and cheaper. (Wed, 04 Oct 2006 18:42:25 GMT)
Group offers genetic code mapping prize
The people who spurred private spaceflight with a $10 million prize are doing the same for personalized medicine. The X Prize Foundation is offering $10 million to the first company that can process the genetic codes of 100 people in just 10 days — an advancement that experts say is still at least five years away. (Wed, 04 Oct 2006 20:39:05 GMT)
Transaction management co Correlix raises $2.8m
Correlix specializes in control and monitoring technologies for automated mapping of business processes in large enterprises. (Wed, 04 Oct 2006 20:55:47 GMT)
Hybrid Nanoparticles for Multimodal Medical Imaging
Research at the University at Buffalo is launching a new generation of medical imaging with nanoparticle-based multi-probe systems in which two or more medical imaging techniques are combined to provide complementary information. (Wed, 04 Oct 2006 23:16:26 GMT)
Remarks by First Lady Laura Bush at Tom Reynolds for Congress Luncheon
The following is a transcript of remarks by First Lady Laura Bush at Tom Reynolds for Congress Luncheon: (Wed, 04 Oct 2006 23:31:00 GMT)
$10 Million Prize Set Up for Speedy DNA Decoding
The terms of the prize, announced by the X Prize Foundation of Santa Monica, Calif., require competitors to sequence 100 human genomes of their choice within 10 days. (Thu, 05 Oct 2006 01:20:32 GMT)
Bio-IT Briefs
October 05, 2006 | The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), on Wednesday announced the latest round of grant awards totaling more than $13.3 million to speed the development of innovative sequencing technologies that reduce the cost of DNA sequencing and expand the use of genomics in medical research and health care. (Thu, 05 Oct 2006 06:30:05 GMT)
New Tool For Understanding Estrogen-Fueled Breast Cancer Provided By Molecular Atlas
Lurking in unexplored regions of the human genome are thousands of previously unknown on/off switches that may influence how the growth of breast cancer is driven by estrogen, new research by Dana-Farber Cancer Institute researchers has revealed. [click link for full article] (Thu, 05 Oct 2006 07:09:57 GMT)
BioDiscovery Releases a New Array CGH Analysis Module for ImaGene 7.0
BioDiscovery Inc., the leading developer of integrated software solutions for microarray research announced today the release of a completely new aCGH module providing an advanced array-based DNA copy number analysis and visualization tool. (PRWeb Oct 5, 2006) Trackback URI: http://www.prweb.com/zingpr.php/WmV0YS1JbnNlLVNpbmctRmFsdS1JbnNlLVplcm8= (Thu, 05 Oct 2006 07:21:32 GMT)
Genetic Map Adds to Cancer Research
A recent study headed by researchers at the Harvard-affiliated Dana-Farber Cancer Institute has identified a complete map of the genetic regions that may influence how estrogen contributes to breast cancer—results that could advance clinical treatment for breast cancer patients. (Thu, 05 Oct 2006 08:22:58 GMT)
Santa Cruz makes move to check growth at UC
The feisty politicians who run Santa Cruz are digging in to fight an ambitious plan that would expand UC-Santa Cruz's size, scope and reputation. Post a Comment (Thu, 05 Oct 2006 09:27:49 GMT)
Genomics: Blueprints for partnerships
Gutless marine worms harness the resources of a team of bacteria in lieu of a digestive or excretory system. A genome-sequence analysis now defines the roles of the microbes. (Thu, 05 Oct 2006 10:12:05 GMT)
Co-evolution of transcriptional and post-translational cell-cycle regulation
DNA microarray studies have shown that hundreds of genes are transcribed periodically during the mitotic cell cycle of humans, budding yeast, fission yeast and the plant Arabidopsis thaliana. Here we show that despite the fact the protein complexes involved in this process are largely the same among all eukaryotes, their regulation has evolved considerably. Our comparative analysis of several (Thu, 05 Oct 2006 10:14:29 GMT)
DNAPrint Genomics Congratulates Biofrontera AG on Successful Clinical Trial Stages for Two Drugs
DNAPrint Genomics, Inc. today announced that two products being developed by Biofrontera AG, a company in Germany in which DNAPrint Genomics owns an 18.3% stake, have been approved for the next stages of their respective clinical trial processes. The products are Biofrontera's BF-200 ALA treatment for actinic keratosis (precancerous and cancerous skin lesions), its lead product, and BF-derm1, a (Thu, 05 Oct 2006 11:00:00 GMT)
IBT Reference Laboratory Appoints Dr. Michelle Hunter Vice President of Sales, Marketing and Corporate Development
IBT Reference Laboratory, an international allergy and immunology laboratory that specializes in contract research for pharmaceutical development, recently named Michelle Hunter, Ph.D., M.B.A. as vice president of sales, marketing and corporate development. (Thu, 05 Oct 2006 11:30:00 GMT)
Scientists Pick Apart Fungus for Genetic Clues
Using the tools of molecular genetics, Agricultural Research Service ( ARS ) scientists are deconstructing the toxin-making machinery of the fungus Fusarium verticillioides to find clues to its contamination of corn. (Thu, 05 Oct 2006 11:37:33 GMT)
BioDiscovery Releases a New Array CGH Analysis Module for ImaGene 7.0
El Segundo, CA (PRWEB) October 5, 2006 -- BioDiscovery Inc. (Thu, 05 Oct 2006 12:00:00 GMT)
Strategic Diagnostics Inc. Announces NPIP Technical Approval and First Commercial Orders for RapidChek(R) SELECT(TM)
NEWARK, Del.----Strategic Diagnostics Inc. , today announced that their new RapidChek® SELECT Salmonella testing product has been approved by the Technical Committee of the National Poultry Improvement Plan as an analytical method for the detection of Salmonella species in NPIP samples. (Thu, 05 Oct 2006 12:40:00 GMT)
Looking ahead
The Wednesday whirl: • The Nobel Prize in chemistry will be announced. • Eyes on the the other prize: The X PRIZE Foundation, which sponsors the largest medical prize in history, announces a second award for breakthroughs in genomics. • Economic numbers:... (Thu, 05 Oct 2006 12:54:11 GMT)
Sequencing Of The Oyster Mushroom Genome
Professor of Microbiology at the Public University of Navarre, Antonio Gerardo Pisabarro de Lucas, is leading an international project to sequence the genome of the oyster mushroom. The oyster mushroom, Pleurotus ostreatus, will be the first edible mushroom in the world to be genetically sequenced. (Thu, 05 Oct 2006 13:02:56 GMT)
Simple, Sensitive New Way To Detect Activity Of Destructive Enzymes
Scientists in the United States are reporting discovery of a much-needed new method to identify the activity of destructive enzymes that have been linked to a range of diseases. (Thu, 05 Oct 2006 13:03:08 GMT)
Cutting-edge Methods For Analyzing Complex Molecular Interactions
With the genomes of hundreds of organisms now catalogued, one of the next major challenges is to identify proteins and their interactions. The current issue of CSH Protocols, published online, features two freely available, cutting-edge methods that address this challenge. (Thu, 05 Oct 2006 13:05:28 GMT)
Helping Build Designs That Are 'Cool'
Cool design creates hot profits, and although really great design is an art rather than a craft, the E-VaN project has developed some best-practice design tools to help companies maximise their potential. E-VaN aims to usher in a new wave of design that allies form with function. (Thu, 05 Oct 2006 13:05:49 GMT)
Douglas Lane, President, CEO and Chairman of Genesis Bioventures Featured in Exclusive Interview With WallSt.net
Genesis Bioventures, Inc. , announced that Douglas Lane, GBIW's President, CEO, and Chairman, was featured in an exclusive interview with WallSt.net. WallSt.net is a professional forum for the financial community, primarily known for interviews with CEOs and prominent business executives. (Thu, 05 Oct 2006 14:30:00 GMT)
New Biomarker Predicts Survival in Colorectal Cancer
New Haven, Conn. — The location and amount of a protein within two separate compartments of a tumor cell may be critical markers predicting survival in colorectal cancer, according to a study at Yale School of Medicine. (Thu, 05 Oct 2006 14:31:14 GMT)
DNAPrint Genomics Congratulates Biofrontera AG on Successful Clinical Trial Stages for Two Drugs
DNAPrint Genomics, Inc. (OTCBB: DNAG) todayannounced that two products being developed by Biofrontera AG, a company inGermany in which DNAPrint Genomics owns an 18.3% stake, have been approvedfor the next stages of their respective clinical trial processes. Theproducts are Biofrontera's BF-200 ALA treatment for actinic keratosis(precancerous and cancerous skin lesions), its lead product, and (Thu, 05 Oct 2006 14:51:52 GMT)
Scientists pick apart Fusarium verticillioides to find clues to its contamination of corn
Using the tools of molecular genetics, Agricultural Research Service (ARS) scientists are deconstructing the toxin-making machinery of the fungus Fusarium verticillioides to find clues to its contamination of corn. (Thu, 05 Oct 2006 15:05:17 GMT)
$10 million prize for mapping human genomes
Read full story for latest details. (Thu, 05 Oct 2006 17:15:01 GMT)
Nanogen Announces Consolidation and Cost Reduction Actions
Nanogen, Inc. , developer of advanced diagnostic products, announced today that it plans to reduce staff in North America by approximately 15% by the end of 2006. (Thu, 05 Oct 2006 17:30:00 GMT)
Nanogen Announces Consolidation and Cost Reduction Actions
Nanogen, Inc. , developer of advanced diagnostic products, announced today that it plans to reduce staff in North America by approximately 15% by the end of 2006. The reduction will be achieved through both attrition and consolidation of activities in R&D, manufacturing, sales and marketing. (Thu, 05 Oct 2006 21:51:57 GMT)
$10 Million Prize Set Up for Speedy DNA Decoding
The terms of the prize, announced by the X Prize Foundation of Santa Monica, Calif., require competitors to sequence 100 human genomes of their choice within 10 days. (Fri, 06 Oct 2006 04:11:08 GMT)
InnovationsKapital Secures SEK 1 Billion for New Investments
STOCKHOLM, Sweden----InnovationsKapital, a well established independent early stage venture capital firm, is pleased to announce the closing of the fourth InnKap fund - InnKap 4 Partners. (Fri, 06 Oct 2006 06:55:00 GMT)
Affymetrix and NimbleGen Systems Enter into Licensing Agreement
SANTA CLARA, Calif. & MADISON, Wis.----Affymetrix Inc. and NimbleGen Systems Inc. announced today that NimbleGen has obtained a non-exclusive, worldwide license to a number of Affymetrix patents covering the manufacture, use and sales of nucleic acid microarrays and related products and services in the research field. (Fri, 06 Oct 2006 12:00:00 GMT)
Phosphopeptide Enrichment Kit comes with necessary controls.
Using technology based on Ga+3 chelate on silica, PhosphoProfile(TM) I offers proteomics researchers advantages such as low non-specific binding, no bias in selectivity of phosphorylation state, maximum sensitivity, and accelerated sample handling. Phosphoproteins are digested with included Proteomics Grade Trypsin, resulting in phosphopeptides captured in spin-tubes. Up to 25 nanomoles of (Fri, 06 Oct 2006 13:02:11 GMT)
Oregon's Center for Coastal Margins to Use Genomics and Proteomics Tools in Research
If you have already registered, then login here . (To avoid this screen in the future, do not logout.) (Fri, 06 Oct 2006 13:56:29 GMT)
Researchers to develop active nanoscale surfaces for biological separations
A team of researchers has received a four-year, $1 million grant from the National Science Foundation to study improved methods for biological separations. Led by Ravi Kane, the Merck Associate Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, the group plans to develop nanoscale surfaces that actively reassemble in the presence of DNA, which could eventually (Fri, 06 Oct 2006 14:20:32 GMT)
NimbleGen licenses Affymetrix patents
NimbleGen Systems Inc. has obtained a non-exclusive, worldwide license to a number of patents from a California firm in a move the Madison biotech firm hopes will accelerate sales. (Fri, 06 Oct 2006 15:11:44 GMT)
Mayo Clinic gets $72 mil grant for developing drug treatments
The National Institutes of Health award The Mayo Clinic a $72 million research grant to speed development and delivery of drugs to patients. The Arizona portion of the money will support Mayo's collaborations with Arizona State University and the Translational Genomics Research Institute. (Fri, 06 Oct 2006 15:15:58 GMT)
Affymetrix in licensing deal with Wisconsin company
Affymetrix Inc. and NimbleGen Systems Inc. said Friday they entered a licensing agreement over some Affymetrix patents covering manufacture, use and sales of nucleic acid microarrys. (Fri, 06 Oct 2006 16:11:31 GMT)
October MCP: A special issue on Clinical Proteomics
The October 2006 issue of the journal Molecular and Cellular Proteomics (MCP) will focus specifically on biomarker discovery and clinical proteomics. This is the fourth special clinical issue produced by the Journal, and it is available free to the public on the MCP website ( www.mcponline.org ). (Fri, 06 Oct 2006 16:21:05 GMT)
Danaos Shares Slip in Debut
Shares of Danaos Corp. fell slightly Friday, as the Greek shipping company had its trading debut on the New York Stock Exchange. (Fri, 06 Oct 2006 17:26:51 GMT)
Danaos Shares Slip in Debut
Shares of Danaos Corp. fell slightly Friday, as the Greek shipping company had its trading debut on the New York Stock Exchange. In early afternoon trading, the shares were down 15 cents from the IPO price of $21. (Fri, 06 Oct 2006 17:40:36 GMT)
What Is Proteomics?
Proteomics is the large-scale study of protein, particularly their structures and functions. This term was coined to make an analogy with genomics, and while it is often viewed as the "next step", proteomics is much more complicated than genomics (Fri, 06 Oct 2006 17:49:02 GMT)
I’m a Celebrity, Get My Sequence!
October 06, 2006 | COMMENTARY | Two years ago, the X Prize Foundation awarded $10 million for the first sub-orbital spaceflight. Now, a new prize -- the Archon X Prize for Genomics -- has been formally established. (Fri, 06 Oct 2006 19:36:00 GMT)
UAlbany researcher gets $2.2M in federal funds for cancer research
A scientist at the University at Albany's Gen*NY*Sis Center for Excellence in Cancer Genomics has won a $2.2 million award from the National Institute of Environmental Health Services. (Fri, 06 Oct 2006 20:19:55 GMT)
Lifeline Therapeutics, Inc. Elects Dr. Larry Gold to Board of Directors; Dr. Gold Brings Decades of Business Leadership
Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, a patent-pending dietary supplement that increases the body's natural antioxidant defenses, today announced the appointment of Larry Gold, Ph.D. to its Board of Directors. Dr. (Fri, 06 Oct 2006 20:23:19 GMT)
SPECTRUM EDITOR TALKS ABOUT FELLOWS
Listen to Susan Hassler, editor-in-chief of IEEE Spectrum , talk about the magazine and about the results of the latest IEEE Fellows Survey ȁ4;concerning tech trends over the next 50 yearsȁ4;today on Science and Society's weekly podcast . Hasslerȁ4;along with Gary Fedder (the Howard M. Wilkoff Professor of Electrical and Computer Engineering and the Director of the Institute for Complex (Fri, 06 Oct 2006 21:30:00 GMT)
$10 Million Prize Set Up for Speedy DNA Decoding
The terms of the prize, announced by the X Prize Foundation of Santa Monica, Calif., require competitors to sequence 100 human genomes of their choice within 10 days. (Sat, 07 Oct 2006 04:12:17 GMT)
Pioneers on genetic frontier
For scientist Johanna Wolford, inspiration may strike when she is swimming or knitting. As she's lapping waves or clacking knitting needles, she lets her mind wander, and it just happens. (Sat, 07 Oct 2006 04:49:14 GMT)
New Biomarker Predicts Survival In Colorectal Cancer
The location and amount of a protein within two separate compartments of a tumor cell may be critical markers predicting survival in colorectal cancer, according to a study at Yale School of Medicine. [click link for full article] (Sat, 07 Oct 2006 19:08:12 GMT)
Researchers To Develop Active Nanoscale Surfaces for Biological Separations
A team of researchers has received a four-year, $1 million grant from the NSF to study improved methods for biological separations. Led by Ravi Kane, the Merck Associate Professor of Chemical and Biological Engineering at Rensselaer, the group plans to develop nanoscale surfaces that actively reassemble in the presence of DNA, which could eventually lead to more efficient separation tools for (Sat, 07 Oct 2006 19:30:02 GMT)
Yale School Of Medicine Awarded $57 Million For Bench-to-Bedside Research
As part of a major national initiative to speed research from the laboratory bench to patients in need, Yale School of Medicine Tuesday received a $57.3 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH).The funding includes $31.5 million in new resources that will greatly strengthen clinical research at Yale and $25. [click link for full article] (Sat, 07 Oct 2006 21:08:00 GMT)
Institutions creating a mecca of Alzheimer's research
The Arizona Alzheimer's Consortium has created a national powerhouse by combining a stellar brain bank, well-known PET scan and MRI programs. (Sun, 08 Oct 2006 03:46:27 GMT)
Pine Crest siblings qualify to take courses at Duke
Boca siblings Blair and James Baker may go to Duke sooner than most. (Sun, 08 Oct 2006 04:14:57 GMT)
Trustee says his tenure stands strong
Editor's note: Ninth in a series focusing on 12 candidates seeking three seats on the Temecula Valley Unified School District board. The election is Nov. 7. (Sun, 08 Oct 2006 05:56:12 GMT)
$10 Million Prize Set Up for Speedy DNA Decoding
The terms of the prize, announced by the X Prize Foundation of Santa Monica, Calif., require competitors to sequence 100 human genomes of their choice within 10 days. (Sun, 08 Oct 2006 06:08:18 GMT)
Institutions creating a mecca of Alzheimer's research
The Arizona Alzheimer's Consortium has created a national powerhouse by combining a stellar brain bank, well-known PET scan and MRI programs. (Sun, 08 Oct 2006 08:47:33 GMT)
1 2 3 4 5 Next
